Abstract
Aptamers. In their Communication (e202218106), Zhi Zhu et al. report the development of aptamer-LYTACs (lysosome targeting chimeras) for the efficient degradation of the platelet-derived growth factor and the membrane protein PTK7 through the lysosomal degradation pathway.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
